Experimental Cancer Drug Shows Promise Against Osteoporosis and Menopausal Weight Gain
Source Summary
University of East Anglia researchers published findings in npj Drug Discovery showing that an experimental cancer drug may protect against osteoporosis, reduce body fat, and reverse some metabolic changes associated with menopause. The compound was originally designed to treat cancer but demonstrates potential benefits for women's health beyond its initial purpose.
Why it matters
The findings suggest a single drug could address multiple health concerns affecting millions of postmenopausal women, potentially offering a new treatment approach for osteoporosis and metabolic complications.
What remains uncertain
The research is experimental and published findings do not confirm efficacy or safety in human clinical trials.
